{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:56:46Z","timestamp":1792814206555,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26293032"],"award-info":[{"award-number":["26293032"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.xphs.2017.04.040","type":"journal-article","created":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T05:17:09Z","timestamp":1493270229000},"page":"2566-2575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Investigation of the Importance of Multidrug Resistance-Associated Protein 4 (Mrp4\/ Abcc4 ) in the Active Efflux of Anionic Drugs Across the Blood\u2013Brain Barrier"],"prefix":"10.1016","volume":"106","author":[{"given":"Kayoko","family":"Kanamitsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kusuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Schuetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.xphs.2017.04.040_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1602\/neurorx.2.1.73","article-title":"Active efflux across the blood-brain barrier: role of the solute carrier family","volume":"2","author":"Kusuhara","year":"2005","journal-title":"NeuroRx"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.040_bib2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1517\/17425255.1.2.233","article-title":"Expression and function of multidrug resistance transporters at the blood-brain barriers","volume":"1","author":"Scherrmann","year":"2005","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"2\u20133","key":"10.1016\/j.xphs.2017.04.040_bib3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0169-409X(98)00085-4","article-title":"P-Glycoprotein, a gatekeeper in the blood-brain barrier","volume":"36","author":"Schinkel","year":"1999","journal-title":"Adv Drug Deliv Rev"},{"issue":"17","key":"10.1016\/j.xphs.2017.04.040_bib4","doi-asserted-by":"crossref","first-page":"7612","DOI":"10.1128\/MCB.24.17.7612-7621.2004","article-title":"Mrp4 confers resistance to topotecan and protects the brain from chemotherapy","volume":"24","author":"Leggas","year":"2004","journal-title":"Mol Cell Biol"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.040_bib5","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1124\/mol.107.034751","article-title":"Effect of breast cancer resistance protein (Bcrp\/Abcg2) on the disposition of phytoestrogens","volume":"72","author":"Enokizono","year":"2007","journal-title":"Mol Pharmacol"},{"issue":"6","key":"10.1016\/j.xphs.2017.04.040_bib6","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1124\/dmd.107.019257","article-title":"Quantitative investigation of the role of breast cancer resistance protein (Bcrp\/Abcg2) in limiting brain and testis penetration of xenobiotic compounds","volume":"36","author":"Enokizono","year":"2008","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.040_bib7","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1124\/jpet.109.162321","article-title":"Kinetic analysis of the cooperation of P-glycoprotein (P-gp\/Abcb1) and breast cancer resistance protein (Bcrp\/Abcg2) in limiting the brain and testis penetration of erlotinib, flavopiridol, and mitoxantrone","volume":"333","author":"Kodaira","year":"2010","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.xphs.2017.04.040_bib8","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00424-006-0054-9","article-title":"Multidrug resistance-associated proteins 3, 4, and 5","volume":"453","author":"Borst","year":"2007","journal-title":"Pflugers Arch"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.040_bib9","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1158\/0008-5472.CAN-06-2680","article-title":"Multidrug resistance protein 4 protects bone marrow, thymus, spleen, and intestine from nucleotide analogue-induced damage","volume":"67","author":"Belinsky","year":"2007","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.040_bib10","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1124\/mol.106.028233","article-title":"Functional involvement of multidrug resistance-associated protein 4 (MRP4\/ABCC4) in the renal elimination of the anti-viral drugs adefovir and tenofovir","volume":"71","author":"Imaoka","year":"2007","journal-title":"Mol Pharmacol"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.040_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1124\/dmd.108.024018","volume":"37","author":"Ose","year":"2009","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.040_bib12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.tips.2008.01.006","article-title":"Multidrug resistance protein 4 (MRP4\/ABCC4): a versatile efflux transporter for drugs and signalling molecules","volume":"29","author":"Russel","year":"2008","journal-title":"Trends Pharmacol Sci"},{"issue":"11","key":"10.1016\/j.xphs.2017.04.040_bib13","first-page":"3144","article-title":"Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system","volume":"62","author":"Chen","year":"2002","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.040_bib14","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1124\/jpet.107.121491","article-title":"Species difference in the inhibitory effect of nonsteroidal anti-inflammatory drugs on the uptake of methotrexate by human kidney slices","volume":"322","author":"Nozaki","year":"2007","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.040_bib15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2174\/138920006774832550","article-title":"Topotecan is a substrate for multidrug resistance associated protein 4","volume":"7","author":"Tian","year":"2006","journal-title":"Curr Drug Metab"},{"issue":"12","key":"10.1016\/j.xphs.2017.04.040_bib16","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1124\/dmd.107.017459","article-title":"Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor","volume":"35","author":"Yamada","year":"2007","journal-title":"Drug Metab Dispos"},{"issue":"12","key":"10.1016\/j.xphs.2017.04.040_bib17","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1007\/s11095-007-9453-7","article-title":"Multichannel liquid chromatography-tandem mass spectrometry cocktail method for comprehensive substrate characterization of multidrug resistance-associated protein 4 transporter","volume":"24","author":"Uchida","year":"2007","journal-title":"Pharm Res"},{"issue":"6","key":"10.1016\/j.xphs.2017.04.040_bib18","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1124\/mol.106.031823","article-title":"Involvement of MRP4 (ABCC4) in the luminal efflux of ceftizoxime and cefazolin in the kidney","volume":"71","author":"Ci","year":"2007","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.040_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1681\/ASN.2005090966","article-title":"Multidrug resistance-associated protein 4 is involved in the urinary excretion of hydrochlorothiazide and furosemide","volume":"18","author":"Hasegawa","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.040_bib20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1124\/dmd.109.029454","article-title":"Functional characterization of mouse organic anion transporting peptide 1a4 in the uptake and efflux of drugs across the blood-brain barrier","volume":"38","author":"Ose","year":"2010","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.040_bib21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1124\/dmd.107.018556","article-title":"P-glycoprotein restricts the penetration of oseltamivir across the blood-brain barrier","volume":"36","author":"Ose","year":"2008","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.040_bib22","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1523-1755.2004.00354.x","article-title":"Characterization of uremic toxin transport by organic anion transporters in the kidney","volume":"65","author":"Deguchi","year":"2004","journal-title":"Kidney Int"},{"issue":"17","key":"10.1016\/j.xphs.2017.04.040_bib23","first-page":"4237","article-title":"The mouse Bcrp1\/Mxr\/Abcp gene: amplification and overexpression in cell lines selected for resistance to\u00a0topotecan, mitoxantrone, or doxorubicin","volume":"59","author":"Allen","year":"1999","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.xphs.2017.04.040_bib24","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s11095-005-7595-z","article-title":"Human multidrug resistance associated protein 4 confers resistance to camptothecins","volume":"22","author":"Tian","year":"2005","journal-title":"Pharm Res"},{"issue":"6","key":"10.1016\/j.xphs.2017.04.040_bib25","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1128\/AAC.01428-08","article-title":"Identification of the efflux transporter of the fluoroquinolone antibiotic ciprofloxacin in murine macrophages: studies with ciprofloxacin-resistant cells","volume":"53","author":"Marquez","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.040_bib26","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00004647-200002000-00020","article-title":"Development of an in situ mouse brain perfusion model and its application to mdr1a P-glycoprotein-deficient mice","volume":"20","author":"Dagenais","year":"2000","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.040_bib27","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1124\/dmd.113.055228","article-title":"The effect of ABCG2 and ABCC4 on the pharmacokinetics of methotrexate in the brain","volume":"42","author":"Sane","year":"2014","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"10.1016\/j.xphs.2017.04.040_bib28","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1158\/1078-0432.CCR-08-2940","article-title":"Functionally overlapping roles of Abcg2 (Bcrp1) and Abcc2 (Mrp2) in the elimination of methotrexate and its main toxic metabolite 7-hydroxymethotrexate in\u00a0vivo","volume":"15","author":"Vlaming","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.040_bib29","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1073\/pnas.93.3.1238","article-title":"P-glycoprotein confers methotrexate resistance in 3T6 cells with deficient carrier-mediated methotrexate uptake","volume":"93","author":"de Graaf","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.xphs.2017.04.040_bib30","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fonc.2012.00178","article-title":"ABCC4\/MRP4: a MYCN-regulated transporter and potential therapeutic target in neuroblastoma","volume":"2","author":"Huynh","year":"2012","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.040_bib31","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1515\/dmdi-2013-0062","article-title":"Role of OATP-1B1 and\/or OATP-1B3 in hepatic disposition of tyrosine kinase inhibitors","volume":"29","author":"Khurana","year":"2014","journal-title":"Drug Metabol Drug Interact"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.040_bib32","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1515\/dmdi-2014-0014","article-title":"Inhibition of OATP-1B1 and OATP-1B3 by tyrosine kinase inhibitors","volume":"29","author":"Khurana","year":"2014","journal-title":"Drug Metabol Drug Interact"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.040_bib33","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1124\/mol.108.045443","article-title":"The proton-coupled folate transporter: impact on pemetrexed transport and on antifolates activities compared with the reduced folate carrier","volume":"74","author":"Zhao","year":"2008","journal-title":"Mol Pharmacol"},{"issue":"36","key":"10.1016\/j.xphs.2017.04.040_bib34","doi-asserted-by":"crossref","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","article-title":"An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex","volume":"34","author":"Zhang","year":"2014","journal-title":"J\u00a0Neurosci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354917302769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354917302769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T09:29:56Z","timestamp":1535880596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354917302769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0022354917302769"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2017.04.040","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of the Importance of Multidrug Resistance-Associated Protein 4 (Mrp4\/Abcc4) in the Active Efflux of Anionic Drugs Across the Blood\u2013Brain Barrier","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2017.04.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}